Community Health Systems (NYSE:CYH - Free Report) had its price target boosted by Truist Financial from $3.50 to $4.25 in a research report report published on Wednesday morning,Benzinga reports. They currently have a hold rating on the stock.
CYH has been the topic of a number of other reports. Wells Fargo & Company restated an "underweight" rating and set a $3.50 price target (up from $2.00) on shares of Community Health Systems in a research report on Thursday, May 29th. Guggenheim assumed coverage on shares of Community Health Systems in a research report on Wednesday, April 9th. They set a "neutral" rating on the stock. Finally, UBS Group set a $3.50 price target on shares of Community Health Systems in a research report on Friday, April 25th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, Community Health Systems presently has an average rating of "Hold" and an average target price of $4.38.
Read Our Latest Analysis on Community Health Systems
Community Health Systems Stock Down 1.1%
Shares of CYH traded down $0.04 during midday trading on Wednesday, hitting $3.60. The company had a trading volume of 1,616,128 shares, compared to its average volume of 2,410,952. Community Health Systems has a 52 week low of $2.24 and a 52 week high of $6.29. The company's 50 day moving average price is $3.62 and its 200 day moving average price is $3.19. The stock has a market cap of $505.12 million, a price-to-earnings ratio of -0.98 and a beta of 2.06.
Community Health Systems (NYSE:CYH - Get Free Report) last posted its quarterly earnings results on Wednesday, April 23rd. The company reported ($0.03) EPS for the quarter, beating the consensus estimate of ($0.10) by $0.07. The business had revenue of $3.16 billion during the quarter, compared to analyst estimates of $3.10 billion. The company's quarterly revenue was up .6% on a year-over-year basis. During the same period last year, the firm posted ($0.14) earnings per share. Equities analysts anticipate that Community Health Systems will post -0.29 EPS for the current fiscal year.
Institutional Trading of Community Health Systems
Several large investors have recently modified their holdings of the company. Tower Research Capital LLC TRC boosted its holdings in Community Health Systems by 250.0% in the 4th quarter. Tower Research Capital LLC TRC now owns 9,023 shares of the company's stock valued at $27,000 after purchasing an additional 6,445 shares during the period. R Squared Ltd boosted its holdings in Community Health Systems by 71.6% in the 1st quarter. R Squared Ltd now owns 10,950 shares of the company's stock valued at $30,000 after purchasing an additional 4,570 shares during the period. Two Sigma Securities LLC bought a new stake in Community Health Systems in the 4th quarter valued at $33,000. Cibc World Markets Corp acquired a new position in shares of Community Health Systems in the 4th quarter valued at $35,000. Finally, Harbor Capital Advisors Inc. acquired a new position in shares of Community Health Systems in the 1st quarter valued at $36,000. 84.99% of the stock is owned by institutional investors.
Community Health Systems Company Profile
(
Get Free Report)
Community Health Systems, Inc owns, leases, and operates general acute care hospitals in the United States. It offers general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric, and rehabilitation services, as well as skilled nursing and home care services.
See Also

Before you consider Community Health Systems, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Community Health Systems wasn't on the list.
While Community Health Systems currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.